Well, if we've learned anything from these past couple of years, my fellow Americans, it's that personal medical freedom and liberty are in crisis.

America Outlaw Pulse brings together the top experts in health care related fields to keep you

a beat ahead.

I'm going to read you this at the top of this release here is, it's eye-opening is what it is,

and an analysis of, listen to this, ivermectin and the benazole

in cancer patients show 84.4% clinical benefit nearly half report cancer disappearance or regression

this is as far as i can see in my world, it's a blockbuster news.

And so after about six months, almost half of the cancer patients taken this product

reported no evidence of disease.

I mean, I don't even know how to parse those words.

That's incredible.

And 32.8% of a tumor regression, 15.6 and 36.1 reported

the disease stabilization. These are tremendous numbers. And you know, with all the fear of cancer,

we talk about, we've talked about a lot of the turbo cancers, we talk about the uprising

in cancer in general. This is eye-opening news. We want to start the broadcast, talk about the uprising cancer in general. This is I

Open a news. We want to start the broadcast, talk about that. My fellow Americans, welcome into

America Out Loud Pulse. It is Malcolm Out Loud here, along with my co-host. Dr. Peter McCullough,

with a lot of good news with this study. So very exciting. Yeah, this is incredible. I had to read it a couple of times, Peter, to believe that it was, I mean, and I look at

the stories and the stats on it, and it's shocking.

Was you shocked to see this?

I was.

You know, the preclinical data had been accumulated in an ivermectin and benbenazole, and each one of the drugs

...